Arm (ARM) unveils first AGI CPU chip for data centre AI workloads, co-developed with Meta
Arm Holdings shares advanced today after the company unveiled its first internally produced AGI CPU chip for data centre AI workloads, co-developed with Meta. The stock is trading at $164.78, up 3.4% from yesterday's close of $159.34, recovering from a 1.2% decline on Wednesday.
The new chip, designed for agentic AI workloads, is projected to generate $15 billion in annual revenue within five years. Following the announcement, Arm raised its earnings forecast to $3.00 per share for fiscal year 2028 and $9.00 per share for fiscal year 2031.
Analyst firms reacted positively to the news. Raymond James upgraded Arm from Market Perform to Outperform, setting a price target of $166.00, while HSBC maintained its Buy rating with a target of $205.00.
Today's upward movement in Arm Holdings shares reflects the market's enthusiastic endorsement of the company's ambitious stride into advanced AI hardware. Investors are clearly looking beyond the immediate quarter, focusing instead on the long-term revenue potential unlocked by Arm's new AGI CPU chip for data centres, co-developed with Meta. This isn't merely about a new product; it signals a significant expansion of Arm's addressable market and validates its core technology as pivotal for cutting-edge artificial intelligence. The market is effectively pricing in the future growth prospects that this strategic move promises.
Understanding Earnings Forecasts and Price Targets
The news highlights two crucial pieces of information that help explain the market's reaction: Arm's raised earnings forecast and analyst price targets. An **earnings forecast** is a company's official projection of its future profitability, often expressed as earnings per share. When Arm raises its forecast, as it did to $3.00 per share for fiscal year 2028 and $9.00 per share for fiscal year 2031, it's essentially telling investors it expects to be significantly more profitable than previously thought. This provides a tangible metric for future value. Complementing this, **price targets** are independent assessments by financial analysts of what a stock *should* be worth, based on their models and assumptions about a company's future performance. Raymond James' upgrade and $166.00 target, alongside HSBC's maintained Buy rating with a $205.00 target, indicate that professional investors believe Arm's current trading price of $164.78 still offers room for appreciation, underpinned by those improved earnings expectations.
The Power of Strategic Partnerships
This event also illustrates the profound impact of strategic partnerships in technology markets. Arm's collaboration with Meta on the AGI CPU chip is more than just a joint development; it's a powerful signal to the entire industry. When a tech giant like Meta, a significant consumer of AI infrastructure, co-develops a chip, it lends immense credibility to the technology and its market viability. This kind of partnership suggests that the new chip isn't just innovative, but also highly relevant and poised for adoption within a critical growth area like data centre AI workloads. Such alliances can accelerate product development, de-risk market entry, and significantly boost investor confidence in a company's long-term trajectory.

Arm Holdings
Arm Holdings plc (ARM) is a foundational technology provider in the semiconductor industry, specialising in the architecture, development, and licensing of central processing unit products and related intellectual property. Its comprehensive offerings, including microprocessors, graphics processing units, and associated software tools, are vital for semiconductor manufacturers and original equipment manufacturers globally. Arm's technology underpins diverse markets such as automotive, computing infrastructure, consumer electronics, and the Internet of Things. The company maintains a significant international presence, with operations spanning the United States, China, Taiwan, and South Korea. Founded in 1990, Arm Holdings plc is headquartered in Cambridge, UK.